id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1991-N-0367-0002,FDA,FDA-1991-N-0367,"Letter from Bristol Laboratories to FDA Dated May 5, 1969",Other,Letter(s),2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,,2014-09-23T13:51:49Z,,0,0,0900006480531022
FDA-1991-N-0367-0005,FDA,FDA-1991-N-0367,Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment,Notice,Notice of Intent,2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,1991-10-29T04:59:59Z,2014-09-23T14:06:50Z,,0,0,0900006480531025
FDA-1991-N-0367-0001,FDA,FDA-1991-N-0367,Kanamycin Sulfate; Kanamycin B Content Testing Method,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,1969-05-27T03:59:59Z,2014-09-23T13:37:35Z,,0,0,0900006480531021
FDA-1991-N-0367-0003,FDA,FDA-1991-N-0367,Request for Extension of Comment Period from Bristol Laboratories Division of Bristol-Myers Co,Other,Request for Extension of Time in which to file a document,2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,,2014-09-23T14:00:22Z,,0,0,0900006480531023
FDA-1991-N-0367-0006,FDA,FDA-1991-N-0367,Withdrawal of Certain Pre-1986 Proposed Rules; Final Action,Notice,Withdrawal,2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,,2014-09-23T14:08:41Z,56FR67440,0,0,0900006480531026